2,4,5-Trifluorotrichloromethyl benzene

We are 2,4,5-Trifluorotrichloromethyl benzene CAS:136364-60-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 2,4,5-Trifluorotrichloromethyl benzene
Other Name: 1,2,4-Trifluoro-5-(trichloromethyl)benzene
CAS No: 136364-60-8
MF: C7H2Cl3F3
MW: 249.44500
Density: 1.626g/cm3
Boiling point: 220.4ºC at 760 mmHg
Flash point: 98.2ºC
Refractive index: 1.502
Vapor Pressure: 0.168mmHg at 25°C
UN Number: N.A
UN Proper Shipping Name: N.A
Transport hazard class: N.A
Packing group: N.A
 
Specification
Appearance: Colorless to light yellow transparent liquid
Purity: ≥98%
Water: ≤0.5%
 
Application: Organic intermediates, pharmaceutical intermediates, agrochemical intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,4,5-Trifluorotrichloromethyl benzene


Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.Triethoxy(2,4,4-trimethylpentyl)silane Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.5-Amino-1H-imidazole-4-carboxamide hydrochloride Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).3-Bromo-4-methylbenzotrifluoride CAS:66417-30-9 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank.

Related Products
Product Name
1-(2,3-Dichlorophenyl)piperazine hydrochloride View Details
(10-Phenylanthracen-9-yl)boronic acid View Details
4-(Toluene-4-Sulfonyloxy)-Piperidine-1-Carboxylic Acid Tert-Butyl Ester View Details
4-chloro-N-methylpyridine-2-carboxamide,hydrochloride manufacturer 3-bromo-9-naphthalen-1-ylcarbazole manufacturer Hexyl nicotinoate manufacturer 2-Anilinoethanol manufacturer D-Ornithine Monohydrochloride manufacturer